ISRCTN86576368
Completed
未知
Development of a screening tool for cardiac involvement in the Sarcoidosis population using cardiac magnetic resonance imaging (MRI) as the gold standard: an observational study
Countess of Chester Hospital (UK)0 sites50 target enrollmentMarch 14, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Sarcoidosis
- Sponsor
- Countess of Chester Hospital (UK)
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with known Sarcoidosis
- •2\. Male and female, aged 18\-65 years
Exclusion Criteria
- •1\. Contraindication for cardiac MRI
- •2\. Any other cardiovascular disease (an exercise tolerance test will be done on all participants to assess for ischaemic heart disease)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Development of a diagnostic method for cardiac amyloidosis by delayed contrast imaging of myocardium using CT.cardiac amyloidosisJPRN-UMIN000053389Fukushima Medical University80
Recruiting
Not Applicable
Cardiac Performance System Data Collection Study - MinnesotaCardiac DiseaseNCT06149143Sensydia Corporation50
Recruiting
Not Applicable
Cardiac Performance System Data Collection StudyCardiac DiseaseNCT05866666Sensydia Corporation115
Completed
Not Applicable
Development and validation of a screening instrument for Obstructive Sleep Apnea Syndrome in healthy workersDisturbed breathingObstructive Sleep Apnea10046304NL-OMON36722Philips Electronics Nederland BV300
Not yet recruiting
Not Applicable
Diagnosis of severe pneumonia using new laboratory and radiological parameters.Health Condition 1: J80- Acute respiratory distress syndromeCTRI/2024/01/061829SHWETHAPRIYA R